Covid update: ‘Delta plus’ variant; plant extract & virus; Novavax’s efficacy

From Novavax’s efficacy to the elderly suffering from abuse, here are the top updates on coronavirus. Novavax’s Covid-19 vaccine showed 90% efficacy in overall clinical trials, the company said. The vaccine will be manufactured for India by the Serum Institute of India (SII). Meanwhile, a plant and root extract of velvetleaf can stop Sars-CoV-2 replication by up to 98%, as per a yet-to-be peer-reviewed study by the government’s CSIR. Also, About 73% elderly population experienced increased abuse during the second lockdown. Watch the full video for more details.